Krakow, Poland · Founded 2017 · Privately Held (backing)
Operator of a medical technology intended to treat several autoimmune diseases. Ongeno is based in Krakow, Poland and was founded in 2017. Its last reported valuation was $72.6 million in Jan 2025. It has raised $3.6 million.
Last reported valuation
$72.6M
Oct 2026
Priced at
—
Total raised
$3.6M
Last round
—
Cap table — not yet on record
Ongeno's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ongeno with a free account
·Watch Ongeno: the Monday email on marks, rounds and moves
